Plotkin Stanley A
Sanofi Pasteur, Doylestown, Pennsylvania, USA.
Clin Infect Dis. 2008 Aug 1;47(3):401-9. doi: 10.1086/589862.
The immune system is redundant, and B and T cells collaborate. However, almost all current vaccines work through induction of antibodies in serum or on mucosa that block infection or interfere with microbial invasion of the bloodstream. To protect, antibodies must be functional in the sense of neutralization or opsonophagocytosis. Correlates of protection after vaccination are sometimes absolute quantities but often are relative, such that most infections are prevented at a particular level of response but some will occur above that level because of a large challenge dose or deficient host factors. There may be >1 correlate of protection for a disease, which we term "cocorrelates." Either effector or central memory may correlate with protection. Cell-mediated immunity also may operate as a correlate or cocorrelate of protection against disease, rather than against infection. In situations where the true correlate of protection is unknown or difficult to measure, surrogate tests (usually antibody measurements) must suffice as predictors of protection by vaccines. Examples of each circumstance are given.
免疫系统具有冗余性,B细胞和T细胞相互协作。然而,几乎所有目前的疫苗都是通过诱导血清或黏膜中的抗体来发挥作用,这些抗体可阻断感染或干扰微生物侵入血液循环。为实现保护作用,抗体必须具备中和或调理吞噬作用的功能。疫苗接种后的保护相关性有时是绝对数量,但通常是相对的,即大多数感染在特定反应水平下可被预防,但由于挑战剂量过大或宿主因素不足,在该水平以上仍可能发生一些感染。一种疾病可能有多种保护相关性,我们称之为“共同相关性”。效应性免疫或中央记忆都可能与保护相关。细胞介导的免疫也可能作为针对疾病而非感染的保护相关性或共同相关性发挥作用。在真正的保护相关性未知或难以测量的情况下,替代检测(通常是抗体检测)必须足以作为疫苗保护作用的预测指标。每种情况都给出了示例。